Trinity Biotech Stock Forecast, Price & News

-0.05 (-2.48 %)
(As of 07/27/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume156,370 shs
Average Volume374,561 shs
Market Capitalization$41.18 million
P/E Ratio16.42
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive TRIB News and Ratings via Email

Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter.

Trinity Biotech logo

About Trinity Biotech

Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the United States, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also develops, manufactures, and distributes products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. The company sells its products through its direct sales force; and a network of independent distributors and strategic partners. Its customers include public health facilities, hospitals, and other outreach facilities, as well as clinical and reference laboratories. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.04 out of 5 stars

Medical Sector

1365th out of 2,218 stocks

Diagnostic Substances Industry

24th out of 38 stocks

Analyst Opinion: 0.0Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Trinity Biotech (NASDAQ:TRIB) Frequently Asked Questions

What stocks does MarketBeat like better than Trinity Biotech?

Wall Street analysts have given Trinity Biotech a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Trinity Biotech wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Trinity Biotech's next earnings date?

Trinity Biotech is scheduled to release its next quarterly earnings announcement on Tuesday, August 24th 2021.
View our earnings forecast for Trinity Biotech

How were Trinity Biotech's earnings last quarter?

Trinity Biotech plc (NASDAQ:TRIB) issued its quarterly earnings data on Monday, May, 24th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.07 by $0.03. The company had revenue of $25.59 million for the quarter. Trinity Biotech had a positive trailing twelve-month return on equity of 1,701.67% and a negative net margin of 2.41%.
View Trinity Biotech's earnings history

How has Trinity Biotech's stock been impacted by Coronavirus?

Trinity Biotech's stock was trading at $1.21 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, TRIB shares have increased by 62.8% and is now trading at $1.97.
View which stocks have been most impacted by COVID-19

Who are Trinity Biotech's key executives?

Trinity Biotech's management team includes the following people:
  • Mr. Ronan O'Caoimh, Chairman & CEO (Age 65, Pay $1.05M)
  • Mr. John Gillard, CFO, Company Sec. & Exec. Director (Age 40, Pay $312k)
  • Dr. James Walsh, Exec. Director (Age 63, Pay $38k)
  • Mr. Kevin Tansley, Exec. Director (Age 50, Pay $757k)
  • Mr. Simon Dunne, Chief Accounting Officer (Age 47)
  • Ms. Eibhlin Kelly, Chief Information Officer (Age 37)
  • Mr. Fernando Devia, Exec. VP of Sales (Age 58)
  • Mr. Sanjiv Suri, Sr. VP of Global Sales & GM of North America (Age 62)

What is Ronan O'Caoimh's approval rating as Trinity Biotech's CEO?

20 employees have rated Trinity Biotech CEO Ronan O'Caoimh on Ronan O'Caoimh has an approval rating of 8% among Trinity Biotech's employees. This puts Ronan O'Caoimh in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Trinity Biotech's key competitors?

What other stocks do shareholders of Trinity Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trinity Biotech investors own include Gilead Sciences (GILD), Novavax (NVAX), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Netflix (NFLX), Pfizer (PFE), QUALCOMM (QCOM), Energy Transfer (ET) and Exxon Mobil (XOM).

What is Trinity Biotech's stock symbol?

Trinity Biotech trades on the NASDAQ under the ticker symbol "TRIB."

How do I buy shares of Trinity Biotech?

Shares of TRIB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Trinity Biotech's stock price today?

One share of TRIB stock can currently be purchased for approximately $1.97.

How much money does Trinity Biotech make?

Trinity Biotech has a market capitalization of $41.18 million and generates $101.98 million in revenue each year.

How many employees does Trinity Biotech have?

Trinity Biotech employs 543 workers across the globe.

What is Trinity Biotech's official website?

The official website for Trinity Biotech is

Where are Trinity Biotech's headquarters?

Trinity Biotech is headquartered at IDA BUSINESS PARK BRAY, WICKLOW L2, .

How can I contact Trinity Biotech?

Trinity Biotech's mailing address is IDA BUSINESS PARK BRAY, WICKLOW L2, . The company can be reached via phone at 353-1276-9800 or via email at [email protected]

This page was last updated on 7/28/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.